Dementia Due to Other General
Medical Conditions
Normal-pressure hydrocephalus is generally
considered the fifth leading cause of dementia after Alzheimer’s, vascular,
al-cohol-related, and AIDS dementias. Long considered reversible but often
merely arrestable, normal-pressure hydrocephalus is a syndrome consisting of
dementia, urinary incontinence and gait apraxia. It results from subarachnoid
hemorrhage, meningitis, or trauma that impedes CSF absorption. Unlike other
dementias, the dementia caused by normal-pressure hydrocephalus has physical
effects that often overshadow the mental effects. Psychomotor retardation,
marked gait disturbances and, in severe cases, com-plete incontinence of urine
occur. A cisternogram is often helpful in the diagnosis, and CT and MRI show
ventricular dilatation without cerebral atrophy. CSF analysis reveals a normal
opening pressure, and glucose and protein determinations are within the normal
range.
The hydrocephalus can be relieved by insertion of a shunt into the lateral ventricle to drain CSF into the chest or abdominal cavity, where it is absorbed. Clinical improvement with shunting approaches 50% with a neurosurgical complication rate of 13 to 25%. Infection remains the most common complication.
Hepatolenticular degeneration (Wilson’s disease) is
an inherited autosomal recessive condition associated with dementia, he-patic
dysfunction and a movement disorder. Localized to chro-mosome 13, this disorder
features copper deposits in the liver, brain and cornea. Symptoms begin in
adolescence to the early twenties and cases are often seen in younger children.
Wilson’s disease should be considered along with Huntington’s disease, AIDS
dementia, substance abuse dementia, head trauma and su-bacute sclerosing
panencephalitis in the differential diagnosis of dementia that presents in
adolescence and early adulthood. Personality, mood and thought disorders are
common, and physical findings include a wing-beating tremor, rigidity,
aki-nesia, dystonia and the pathognomonic Kayser–Fleischer ring around the
cornea. Wilson’s disease can mimic other conditions including Huntington’s
disease, Parkinson’s disease, atypical psychosis and neuroleptic-induced
dystonia. Slit-lamp ocular examination, abnormal liver function tests and
markedly de-creased serum ceruloplasmin levels are diagnostic. Chelating agents
such as penicillamine, if administered early, can reverse central nervous
system and nonneurological findings in about 50% of cases.
In addition to the conditions mentioned previously,
other medi-cal illnesses can be associated with dementia. These include
endocrine disorders (hypothyroidism, hypoparathyroidism), chronic metabolic
conditions (hypocalcemia, hypoglycemia), nutritional deficiencies (thiamine,
niacin, vitamin B12), struc-tural lesions (brain tumors, subdural
hematomas) and multiple sclerosis.
Most of the treatment strategies for dementia have
been dis-cussed previously (see treatment of dementia of the Alzheimer type).
In summary, the management of dementia involves 1) identification and, if
possible, correction of the underlying cause; 2) environmental manipulation to
reorient the patient; 3) intervention with the family by means of education,
peer support, providing access to community organizations, dis-cussing powers
of attorney, living wills, and institutionaliza-tion if appropriate, and
arranging therapy if indicated; and 4) pharmacological management of
psychiatric symptoms and behavior. Low dose antipsychotics with minimal
anticholin-ergic potential and occasionally short-acting benzodiazepines (e.g.,
lorazepam) are the drugs of choice. Because depression occasionally accompanies
dementia, pharmacotherapy with antidepressants of low anticholingeric and
hypotensive poten-tial is often indicated. For patients with dementia,
secondary to drug or alcohol abuse, appropriate referral for rehabilitation is
essential.
Related Topics
Privacy Policy, Terms and Conditions, DMCA Policy and Compliant
Copyright © 2018-2023 BrainKart.com; All Rights Reserved. Developed by Therithal info, Chennai.